IntroductionRheumatic Fever represents a serious public health problem in developing
countries, with thousands of new cases each year. It is an autoimmune
disease, which occurs in response to infection by streptococcus A.ObjectiveThe aim of this study was to evaluate the immunolabeling and protein
expression for endothelin-1 and 3 (ET-1, ET-3) and its receptors (ETA, ETB)
in rheumatic mitral valves.MethodsImmunohistochemistry was used to identify ET-1/ET-3 and ETA/ETB receptors in
rheumatic and control mitral valves. Quantitative analysis of immunostaining
for ET-1/ET-3 and ETA/ETB receptors was performed. In addition, western blot
analysis was carried out to assess protein levels in tissue samples.ResultsET-1 and ETA receptor immunostaining predominated in stenotic valves, mainly
associated with fibrotic regions, inflammatory areas and neovascularization.
Quantitative analysis showed that the average area with positive expression
of ET-1 was 18.21±14.96%. For ETA and ETB, the mean expressed areas
were respectively 15.06±13.13% and 9.20±11.09%. ET-3 did not
have a significant expression. The correlation between the expression of
both endothelin receptors were strongly positive (R=0.74,
P=0.02), but the correlation between ET-1 and its receptor
were negative for both ETA (R=-0.37, P=0.25), and ETB
(R=-0.14, P=0.39). This data was supported by western blot
analysis.ConclusionThe strong correlation between ET-1 and its receptors suggests that both play
a role in the pathophysiology of rheumatic mitral valve stenosis and may
potentially act as biomarkers of this disease.